Home » Topics » BioWorld Science

BioWorld Science
RSS

Collagenase clostridium histolyticum improves foot function in plantar fibromatosis study

Aug. 3, 2021

China's NMPA approves INDs for IASO's CD19/CD22 CAR-T therapy

Aug. 3, 2021

Gem gene sparkles as ischemic stroke drug discovery target

Aug. 3, 2021

Phase II data show safety and efficacy of OCS-02 in dry eye disease

Aug. 3, 2021

Discovery of SR-42667: a tau-SH3 interaction inhibitor that prevents Abeta toxicity

Aug. 3, 2021

Prometheus initiates phase IIa APOLLO-CD study of PRA-023 in Crohn's disease

Aug. 3, 2021

Dosing begins in phase I study of mRNA-6231

Aug. 3, 2021

FDA clears IND for phase I/II MARINA study of AOC-1001

Aug. 3, 2021

Ascentage Pharma discovers mutant GTPase KRAS inhibitors

Aug. 3, 2021

New CDK and TRK inhibitors identified at Hangzhou Innogate Pharma

Aug. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...